Systemic induction of HO-1 by treatment with hemin or cobalt protoporphyrin in ob/ob mice or Zucker rats has been shown to reduce adiposity and improve insulin sensitivity in the diabetic animals [24], [25], [26], suggesting the potential of HO-1 as a therapeutics for type II diabetes. This evidence concerns the gene HMOX1 and type 2 diabetes mellitus.